AKT1 and neoplasm: In the context of thyroid cancer, acetylcholine can induce the expression of PD-L1 in tumor stem cells through the activation of the CD133-Akt pathway, thereby augmenting their resistance against CTLs (Cytotoxic T Lymphocytes) (53).